Smartphone-related pain and discomfort in hand osteoarthritis, rheumatoid arthritis, and psoriatic arthritis: results from the monocentric cross-sectional PHONERIC study

Evolution of bone mineral density after 5 years of TNF-alpha inhibitors in axial spondyloarthritis

Apremilast successfully treats cutaneous polyarteritis nodosa associated with SAPHO syndrome

Post-traumatic stress disorder prior to diagnosis is as rare in spondyloarthritis as in non-inflammatory rheumatic conditions and rheumatoid arthritis

Transdermal capsaicin in hand osteoarthritis: A preliminary study

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis

Development and Validation of a Predictive Model of Hypovitaminosis D in General Adult Population: SCOPYD Study

French survey on the crossed needs on sexual health for chronic inflammatory rheumatism patients and healthcare professionals

Evaluation of the Implementation of Guidelines on the Treatment of Osteoporosis in Patients with Rheumatoid Arthritis

Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients

Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis

Psoriatic arthritis treated by anti-TNFs: a monocentric trial of 102 cases in Auvergne, France

Performance of Fibromyalgia Rapid Screening Tool (FiRST) to detect fibromyalgia syndrome in rheumatic diseases

The SAPHO syndrome: a single-center study of 41 adult patients

Refractory rheumatic disorder: atypical postpregnancy osteoporosis

Parkinson's disease: A risk factor for osteoporosis

[Refractory hypocalcemia]

Construction and utilization of a script concordance test as an assessment tool for DCEM3 (5th year) medical students in rheumatology

Effects of 14 weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis

Osteoporosis treatment in postmenopausal women after peripheral fractures: impact of information to general practitioners

Retention rates of adalimumab, etanercept, and infliximab as first- or second-line biotherapies for spondyloarthritis patients in daily practice in Auvergne (France)

Retention rates of adalimumab, etanercept and infliximab as first-line biotherapy agent for rheumatoid arthritis patients in daily practice - Auvergne experience

Glucocorticoid trajectories over 2 years in patients with rheumatoid arthritis in a real-life setting

Effect of Corticosteroid Injections on Blood Glucose Levels in Diabetic Patients

Prevalence of Migraine and Neuropathic Pain in Rheumatic Diseases

Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures

Efficacy and safety of capsaicin 8% patches: The experience of a rheumatology department

Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial

Mixed effect of tocilizumab in spondylarthritis. Comments about the article by Wendling et al. entitled "Short-term effect of IL-6 inhibition in spondylarthritis". Joint Bone Spine 2010;77:624-5

Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial

Postmenopausal Osteoporosis, Endothelial Dysfunction, and Cardiovascular Risk